Automated tissue characterisation

Precise fast, consistent quantification of tissue perfusion

Non-invasive and point-of-care

Delivers new insights into various disease states at the point-of-care

Software only transformation of the utility of ultrasound for multiple disease states

Transformational capability

An innovative ultrasound diagnostic technology with advanced analysis of 3D sonograms for precisely quantifying tissue perfusion

At Oxailis, we are revolutionizing ultrasound by delivering advanced analysis of 3D sonograms that precisely quantifies tissue perfusion to enable new clinical insights pertaining to multiple disease states.

Obstetrics | Cancer | Nephrology

Revolutionizing diagnostic technology for accurate tissue perfusion quantification across multiple clinical applications

Automated Diagnostic Precision

Our software-only technology enhances existing hardware enabling precise tissue perfusion characterization that is beyond the current standard-of-care.

Advanced 3D Analysis

We use Artificial Intelligence ('AI') based software to analyse 3D sonograms to provide comprehensive understanding in obstetrics, cancer, and nephrology.

Professor Stephen Contag, Fetal Medicine Specialist & Obstetrician, University of Minnesota, USA

"Implementing this type of intervention in conjunction with currently accepted standards of care could have a significant impact... would potentially lead to large economic and community related benefits... compared to the current clinical and history-based screening recommended by the United States Public Health Services"

Reach out to us to discuss our innovative ultrasound diagnostic technology and its applications